Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating PF-07275315 for moderate-to-severe asthma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• PF-07275315 (PF-07275315)

Snippet

Sponsor: Pfizer | Conditions: Asthma | Phase 2 | Status: RECRUITING